Online physician reviews don't correlate with patient satisfaction surveys

Negative online physician reviews are not mimicked in patient satisfaction surveys, according to a study published April 2018 in Mayo Clinic Proceedings.

A physician’s online profile and rating are normal metrics for patients selecting a physician. But what if the rating does not match actual patient satisfaction? In this study, researchers examined online physician reviews and compared ratings to data collected in patient satisfaction surveys.

“Our study highlights the disconnection between industry-vetted patient satisfaction scores and online review comments,” said Sandhya Pruthi, MD, an internal medicine physician at Mayo Clinic, who was the senior author. “Patients need to be aware of these distinctions as they make decisions about their health. Physicians also need to be aware, as they manage their online reputations.”

The study used Google searches and alerts from September to December 2014 to track negative online reviews of Rochester campus Mayo Clinic physicians. Researchers then compared results to data collected from formal patient satisfaction surveys of other Mayo Clinic physicians who had no negative online reviews.

Of the 2,148 physicians analyzed, 113 had negative online reviews spanning 28 departments. Results showed no statistical difference in overall scores or sources for patient communication and interaction. However, physicians with negative online reviews included variables not linked to care including interactions with desk staff, nursing, physical environment, appointment access, wait times, billing and parking.

“These findings … underscore the totality and integrity of processes, elements and encounters – and not just the patient-provider interaction—that all need to be effectively and cohesively in place to ensure optimal patient experience and welfare,” said Bradley Leibovich, MD, a Mayo Clinic urologist.

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.